Author

Emily A. Semmel

Observed name: Emily Semmel

Institution: American Society of Hematology

Observed institutions: American College of Cardiology, American Society of Hematology

OpenAlex ID: A5097081156

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant

2023 · Christopher P. Cannon, Joseph M. Kim, et al. · JAMA Network Open · 21

Accelerating novel therapies for sickle cell disease with RWE: ASH RC Data Hub as a strategically coordinated registry network

2025 · William A. Wood, Osman N. Yogurtcu, et al. · Blood Advances · 1

Feasibility and Implementation of the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections

2024 · William A. Wood, Emily A. Semmel, et al. · Blood · 1

Initial Results from the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections

2024 · Saad Z. Usmani, Emily A. Semmel, et al. · Blood · 1

A pandemic preparedness network for individuals living with compromised immune systems

2023 · William A. Wood, Kenneth C. Anderson, et al. · Blood Advances · 1

Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma

2026 · William A. Wood, Shaji K. Kumar, et al. · Blood Advances

High concordance of physician-attestation with manual data abstraction for sickle cell type: an ASH RC Data Hub study

2026 · Alexis A. Thompson, Ashima Singh, et al. · Blood Advances

Impact of race and social deprivation on outcomes with modern day induction therapy in patients with newly diagnosed multiple myeloma: An ASH research collaborative data hub analysis

2025 · Hamza Hashmi, Meera Mohan, et al. · Blood

Defining functional high-risk multiple myeloma in the era of modern induction therapy

2025 · Barry Paul, Carlyn Tan, et al. · Blood

Development of the ASH Research Collaborative Multiple Myeloma Program: A Multicenter, Real-World Evidence Generation Network

2024 · Shaji Kumar, William A. Wood, et al. · Blood

High Concordance between Investigator-Verified Diagnosis and Manual Data Abstraction for Sickle Cell Diagnosis Type: An ASH Research Collaborative Data Hub Validation Study

2024 · Alexis Thompson, Ashima Singh, et al. · Blood

Works count: 11

Citation count: 25

H-index: 1

I10-index: 1